International Journal of Hematology and Oncology 2023, Vol 33, Num 4 Page(s): 183-187
Hypersensitivity to Procarbazine and Severe RSV Pneumonia in a Child with Hodgkin’s Lymphoma

Dilek INCE 1, Duygu OLMEZ2, Tolga F. KOROGLU3, Arzu B. HOCAOGLU2, Secil A. CAMLAR4, Kamer M. UYSAL1, Nevin UZUNER2, Nur OLGUN1

1Dokuz Eylul University Institute of Oncology, Department of Pediatric Oncology, Izmir, Turkey
2Dokuz Eylul University, Faculty of Medicine, Department of Pediatric Allergy, Izmir, Turkey
3Dokuz Eylul University, Faculty of Medicine, Department of Pediatrics, Pediatric Intensive Care Unit, Izmir, Turkey
4Dokuz Eylul University, Faculty of Medicine, Department of Pediatrics, Izmir, Turkey

Keywords: Procarbazine, Chemotherapy, Hypersensitivity, Skin reaction, Pulmonary toxicity, Treatment, Child, Respiratory
Herein we report respiratory syncytial virus (RSV) pneumonia in a child who had hypersensitivity to procarbazine. Urticarial plaques, maculopapular rash occurred in a child with Hodgkin’s lymphoma while receiving procarbazine. Clinical improvement was achieved by withdrawal of procarbazine, administration of corticosteroids, diphenhydramine. After receiving the next course with bleomycin containing chemotherapy, RSV pneumonia developed which required prolonged mechanical ventilation and was treated with oral ribavirin. Hypersensitivity to procarbazine can be a life treating condition. Omitting procarbazine may be necessary. Respiratory syncytial virus pneumonia in the setting of both immunsupression and procarbazine / bleomycin toxicity may have a more serious course.